Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin versus protease inhibitor switching for hypercholesterolaemia in HIV-infected adults
2013-000486-37Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Percentage change from baseline in total cholesterol at 12 weeks. Started Jul 2013; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2013-000486-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000486-37.